IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of$0.02. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +50.00$0.03 per share when it actually produced a loss of $0.02, delivering a surprise of +33.33%.Over the last four quarters, the company has surp ...